Canada Optimi receives amendment from Health Canada permitting MDMA production Vancouver producer to supply synthetic psychedelic compounds to designated investigators and companies Rowan Dunne9 hours ago
International Short Wave and Sheba partner for clinical trial aimed at combatting anorexia Innovative new studies in the Middle East receive approval from Israeli Ministry of Health Rowan Dunne1 day ago
Research Lobe Sciences partners with iNGENū for new clinical trials in Australia Canadian biopharmaceutical company will receive government tax incentive for studies down under Rowan Dunne4 days ago
Psychedelics Serenus Global becomes Health Canada licensed psilocybin distributor Multi-disciplinary controlled substance company set to commence operations at Calgary facility Rowan Dunne5 days ago
Culture Sisters in Psychedelics host inaugural summit in Vancouver this September Upcoming event said to feature powerful female speakers from broad cross-section of practices and expertise Rowan Dunne6 days ago
Canada Optimi Health partners with patient advocate to launch new psilocybin product The company and Hartle will host a virtual press conference scheduled for Wednesday at 1 pm Natalia Buendia CalvilloAugust 9, 2022
Psychedelics DOSED 2 set to premiere at Vogue Theatre in Vancouver Award-winning documentary sequel to be followed by Q&A with renowned psychedelic community figures Rowan DunneJuly 29, 2022
Canada TheraPsil launches Project Solace, Filament Health offers support 'Largest' psilocybin access and data campaign intended to forward mission of promoting fungi-assisted psychotherapy Rowan DunneJuly 28, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022
Psychedelics PSYC Corp makes successful psychedelic investments Company stock portfolio appreciates significantly since January 2021 Rowan DunneJuly 5, 2022